MedTrace Logo

Treatment of the Postthrombotic Syndrome With the Oblique Stent - TOPOS Study

NCT02942394 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2021-01-12

No results posted yet for this study

Summary

Primary objective:

To assess the efficacy of the stents (sinus-Obliquus stent for the common iliac vein, the sinus-XL Flex stent or sinus-Venous stent for the external iliac and common femoral veins) by evaluating different gradations of patency rates, patient's rating of disease severity and quality of life in patients with post-thrombotic syndrome and concomitant common iliac vein compression.

Secondary objective:

To assess long-term safety of venous stenting

Conditions

  • Post-thrombotic Syndrome
  • Iliac Vein Compression Syndrome

Interventions

DEVICE

sinus-Obliquus Stent System

Sponsors & Collaborators

  • Optimed Medizinische Instrumente GmbH

    lead INDUSTRY

Principal Investigators

  • Nils Kucher, Prof. Dr. med. · Director Clinic for Angiology Universitätsspital Zürich

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2020-12-17
Completion
2020-12-17

Countries

  • Austria
  • Germany
  • Netherlands
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02942394 on ClinicalTrials.gov